FDA Approval Summary

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

FDA Approval Summary

Jul 29, 2024, 13:24 | Insight

Gautam Mehta et al. summarize the FDA accelerated approval of fam-trastuzumab deruxtecan-nxki - FDA Oncology

FDA Oncology shared a post on X about a paper titled "FDA approval summary: fam-trastuzumab…

Mar 15, 2024, 18:07 | Insight

Talazoparib in Combination With Enzalutamide for Prostate Cancer - FDA Oncology

FDA Oncology posted on X/Twitter: "FDA Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment…

All: 2 Posts: 1 - 100

'

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

'

15 Posts Not to Miss from EACR 2025

'

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

'

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

'

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023